Novartis AG (NVS)
97.39
+2.27
(+2.39%)
USD |
NYSE |
Apr 23, 15:45
Novartis Price to Book Value: 4.266 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 4.166 |
| April 19, 2024 | 4.133 |
| April 18, 2024 | 4.055 |
| April 17, 2024 | 4.077 |
| April 16, 2024 | 4.082 |
| April 15, 2024 | 4.135 |
| April 12, 2024 | 4.096 |
| April 11, 2024 | 4.132 |
| April 10, 2024 | 4.134 |
| April 09, 2024 | 4.196 |
| April 08, 2024 | 4.182 |
| April 05, 2024 | 4.196 |
| April 04, 2024 | 4.244 |
| April 03, 2024 | 4.133 |
| April 02, 2024 | 4.135 |
| April 01, 2024 | 4.199 |
| March 28, 2024 | 4.237 |
| March 27, 2024 | 4.200 |
| March 26, 2024 | 4.173 |
| March 25, 2024 | 4.193 |
| March 22, 2024 | 4.215 |
| March 21, 2024 | 4.208 |
| March 20, 2024 | 4.207 |
| March 19, 2024 | 4.219 |
| March 18, 2024 | 4.201 |
| Date | Value |
|---|---|
| March 15, 2024 | 4.260 |
| March 14, 2024 | 4.298 |
| March 13, 2024 | 4.336 |
| March 12, 2024 | 4.37 |
| March 11, 2024 | 4.44 |
| March 08, 2024 | 4.411 |
| March 07, 2024 | 4.377 |
| March 06, 2024 | 4.496 |
| March 05, 2024 | 4.472 |
| March 04, 2024 | 4.466 |
| March 01, 2024 | 4.470 |
| February 29, 2024 | 4.422 |
| February 28, 2024 | 4.477 |
| February 27, 2024 | 4.518 |
| February 26, 2024 | 4.522 |
| February 23, 2024 | 4.551 |
| February 22, 2024 | 4.503 |
| February 21, 2024 | 4.492 |
| February 20, 2024 | 4.499 |
| February 16, 2024 | 4.388 |
| February 15, 2024 | 4.364 |
| February 14, 2024 | 4.338 |
| February 13, 2024 | 4.339 |
| February 12, 2024 | 4.403 |
| February 09, 2024 | 4.425 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.588
Minimum
Sep 26 2022
5.469
Maximum
Oct 02 2023
3.709
Average
3.783
Median
Price to Book Value Benchmarks
| Sandoz Group AG | -- |
| Roche Holding AG | 5.714 |
| Amgen Inc | 23.53 |
| Incyte Corp | 2.242 |
| MorphoSys AG | 49.88 |
Price to Book Value Related Metrics
| PE Ratio | 13.72 |
| PS Ratio | 3.992 |
| PEG Ratio | 0.1100 |
| Price to Free Cash Flow | 17.40 |
| Price | 97.39 |
| Earnings Yield | 7.29% |
| Market Cap | 199.07B |
| PEGY Ratio | 0.1066 |
| Operating PE Ratio | 20.12 |
| Normalized PE Ratio | 23.24 |